Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Ngm Biopharmaceuticals Inc patents


Recent patent applications related to Ngm Biopharmaceuticals Inc. Ngm Biopharmaceuticals Inc is listed as an Agent/Assignee. Note: Ngm Biopharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Ngm Biopharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Ngm Biopharmaceuticals Inc-related inventors


Methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases

The invention relates to variants and fusions of fibroblast growth factor 19 (fgf19), variants and fusions of fibroblast growth factor 21 (fgf21), fusions of fgf19 and/or fgf21, and variants or fusions of fgf19 and/or fgf21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.. . ... Ngm Biopharmaceuticals Inc

Compositions and methods of use for treating metabolic disorders

Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.. . ... Ngm Biopharmaceuticals Inc

Binding proteins and methods of use thereof

The present disclosure provides binding proteins, such as antibodies, that bind beta klotho, including human beta klotho, and methods of their use.. . ... Ngm Biopharmaceuticals Inc

Compositions and methods of use for treating metabolic disorders

Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.. . ... Ngm Biopharmaceuticals Inc

Compositions and methods of use for treating metabolic disorders

Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.. . ... Ngm Biopharmaceuticals Inc

Methods of using compositions comprising fusion variants of fgf19 polypeptides for reducing glucose levels in a subject

The invention relates to variants and fusions of fibroblast growth factor 19 (fgf19), variants and fusions of fibroblast growth factor 21 (fgf21), fusions of fibroblast growth factor 19 (fgf19) and/or fibroblast growth factor 21 (fgf21), and variants or fusions of fibroblast growth factor 19 (fgf19) and/or fibroblast growth factor 21 (fgf21) proteins and peptide sequences (and peptidomimetics), having one or more activities, such as glucose lowering activity, and methods for and uses in treatment of hyperglycemia and other disorders.. . ... Ngm Biopharmaceuticals Inc

Binding proteins and methods of use thereof

The present disclosure provides binding proteins, such as antibodies, that bind to a gdnf family receptor alpha like (gfral) protein, including human gfral protein, and methods of their use.. . ... Ngm Biopharmaceuticals Inc

Compositions and methods of use for treating metabolic disorders

Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.. . ... Ngm Biopharmaceuticals Inc

Pharmaceutical compositions comprising peptide variants and methods of use thereof

Provided herein are pharmaceutical compositions, formulations and dosage forms comprising variants of fibroblast growth factor 19 (fgf19) proteins and peptide sequences (and peptidomimetics) and fusions of fgf19 and/or fibroblast growth factor 21 (fgf21) proteins and peptide sequences (and peptidomimetics), and variants of fusions of fgf19 and/or fgf21 proteins and peptide sequences (and peptidomimetics). Methods of using the pharmaceutical compositions, formulations and dosage forms are also provided herein.. ... Ngm Biopharmaceuticals Inc

Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases

Provided herein are methods of modulating bile acid homeostasis or treating a bile-acid related or associated disorder, comprising using variants and fusions of fibroblast growth factor 19 (fgf19), variants and fusions of fibroblast growth factor 21 (fgf21), fusions of fgf19 and/or fgf21, and variants or fusions of fgf19 and/or fgf21 proteins and peptide sequences (and peptidomimetics), in combination with agents effective in modulating bile acid homeostasis or treating a bile-acid related or associated disorder.. . ... Ngm Biopharmaceuticals Inc

Methods and compositions for the treatment of metabolic disorders and diseases

Provided herein are variants and fusions of fibroblast growth factor 19 (fgf19), variants and fusions of fibroblast growth factor 21 (fgf21), fusions of fgf19 and/or fgf21, and variants or fusions of fgf19 and/or fgf21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as glucose lowering activity, and methods for and uses in treatment of hyperglycemia and other disorders.. . ... Ngm Biopharmaceuticals Inc

Compositions and methods for targeting a pathway

The present disclosure provides a composition comprising an agent that modulates binding of vista to lrig1; and further provides methods of modulating binding of vista to lrig1. The present disclosure provides a composition comprising an agent that modulates binding of hhla2 to kir3dl3; and further provides methods of modulating binding of hhla2 to kir3dl3.. ... Ngm Biopharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ngm Biopharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ngm Biopharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###